AGP Picks
View all

Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on October 30, 2026

Allsup Highlights SSDI Support For Workers With Breast Cancer During Breast Cancer Awareness Month
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
CMMB Celebrates New Distribution Center at the Brethren Service Center with Ribbon-Cutting Ceremony
Human Expertise Meets AI: MedVirtual’s Approach to the Future of Healthcare Administration
MICRIVA Launches New Microdart Spot Care Patch for Targeted Blemished Skin Support
Boehringer Ingelheim registers Phase III trial investigating verducatib in COPD
Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
Why Kraig Labs’ Spider Silk Could Have a Future in Aerospace
NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage
Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin
Akari Therapeutics to Highlight Novel RNA-Splicing ADC Payload Strategy at the 3rd Annual ADC Payload Summit
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases
Press Release Biocartis NV: Biocartis to Present Initial Development Data for Ultra-Rapid Idylla™ Breast21 Assay at SABCS 2026
BioNexus Launches New Corporate Website with Expanded Business and Investor Resources
Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association
Femasys Appoints John Moorhead to Board of Directors
Atsena Therapeutics Reports New Preclinical Data Demonstrating Robust MYO7A Expression and Favorable Safety for ATSN-301, a Laterally Spreading Dual AAV Vector-based Gene Therapy for Usher Syndrome Type 1B
Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027
CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health News of Alabama

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.